Information Provided By: 
Fly News Breaks for October 5, 2018
SMLR
Oct 5, 2018 | 09:00 EDT
Dougherty analyst Kyle Bauser initiated Semler Scientific with a Buy and $48 price target saying the company has performed an impressive turnaround since coming public in 2014, delisting in 2016, and having reached profitability while growing sales 115%. Bauser believes the company can maintain 35%+ sales growth over the next year and generate enough profits to be eligible to uplist by 2Q19.
News For SMLR From the Last 2 Days
There are no results for your query SMLR
